Danaher | DHR - Ebitda


Danaher reported $1.92B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Agilent USD 456M 84M Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD 983.8M 1.36B Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
ESCO Technologies USD 76.38M 11.33M Mar/2026
Fortive USD 314M 25.3M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Illumina USD 469M 137M Dec/2025
Intuitive Surgical USD 1.09B 165.5M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Keysight Technologies USD 519M 71M Dec/2025
Laboratory Of America USD 605.6M 17.5M Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Quidel USD 108.7M 44.6M Mar/2026
Repligen USD 40.01M 469K Mar/2026
Revvity USD 272.91M 24M Mar/2026
Roper Industries USD 858.2M 39.2M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025